Back

Uninterrupted trumps interrupted vitamin k antagonists as peri-atrial fibrillation ablation strategy - a network meta-analysis of safety in more than 25000 patients

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Stroke prediction and prevention with left atrial appendage closure Oral Anticoagulation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Obaida Makdah

Clinic Niederlausitz, Senftenberg (Germany)

7 More presentations in this session

Presentation thumbnail
Real world data on left atrial appendage closure after severe gastrointestinal bleeding in anticoagulated patients with atrial fibrillation: frequency and associated factors.
Doctor A. Martinez Ballesta (Granada, ES)
Abstract Slides Video
Presentation thumbnail
Real world data on left atrial appendage closure after intracranial haemorrhage in anticoagulated patients with atrial fibrillation: frequency and associated factors.
Doctor L. Fernandez Ruz (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Stroke risk of females versus males in asian patients with atrial fibrillation: a temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Association between rivaroxaban and the prognosis of patients with acute myocardial infarction and new-onset atrial fibrillation
Doctor Y. Zheng (Tianjin, CN) Doctor T. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Association between comprehensive management of cardiovascular comorbidities and the risk of stroke in patients with new-onset atrial fibrillation
Doctor J. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prediction and prevention with left atrial appendage closure

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Interrupted or uninterrupted direct oral anticoagulants for atrial aibrillation ablation which is the best strategy insights from a network meta-analysis
thumbnail
Congress Presentation
Interrupted vs uninterrupted direct oral anticoagulants compared with uninterrupted vitamin K antagonists for atrial fibrillation ablation - A meta-analysis of safety
thumbnail
Congress Presentation
Anticoagulation strategy of choice for atrial fibrillation ablation - a network meta-analysis of complication rates

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources